Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

90.0%

+3.4% vs benchmark

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

56%

5 of 9 completed with results

Key Signals

5 with results90% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (4)
P 1 (1)
P 2 (1)
P 4 (4)

Trial Status

Completed9
Unknown1
Not Yet Recruiting1
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (12)

Research Network

Activity Timeline